Picture of Genocea Biosciences logo

GNCAQ — Genocea Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Genocea Biosciences Inc - Expect Gen-009 Phase 1/2A Part B Readout In Q3

April 30 (Reuters) - Genocea Biosciences Inc  GNCA.O :
    * GENOCEA BIOSCIENCES INC - EXPECT GEN-009 PHASE 1/2A PART B
READOUT IN Q3
    * GENOCEA BIOSCIENCES INC - CLINICAL STAGE PROGRAMS GEN-009
AND
GEN-011 CONTINUE TO ADVANCE ANTICIPATE GEN-011 IND FILING IN Q2
    * GENOCEA BIOSCIENCES INC - GEN-011 VIRTUAL SYMPOSIUM
PLANNED FOR
MAY 12TH
    * GENOCEA BIOSCIENCES- EXPECTS THAT ITS EXISTING CASH AND
CASH
EQUIVALENTS ARE SUFFICIENT TO SUPPORT ITS OPERATIONS INTO THE Q1
OF 2021

Source text for Eikon:  ID:nGNX1NPWBc 
Further company coverage:  GNCA.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Genocea Biosciences

See all news